How many capsules of bimetinib/bemetinib capsules are in a box?
Binimetinib is mainly marketed in the form of oral tablets, each tablet containing 15 mg of bimetinib. In the market, common packaging specifications include 15mg×84 tablets and 15mg×168 tablets. These packaging sizes meet patients with different treatment needs, especially for patients requiring long-term treatment. Larger format packaging can reduce the trouble of frequent purchases and ensure the continuity of drug therapy.
For patients who require short-term treatment,15 mg × 84 tablets may be sufficient, while for those with longer treatment times, 15 mg × 168 tablets may provide a longer supply of medication. The selection of these specifications allows patients to flexibly choose drug packaging according to their treatment cycle and doctor's recommendations, and ensures an adequate supply of drugs during treatment.

Specifically, each box15 mg × 84 tablets contains 84 15 mg bimetinib capsules. According to the treatment plan, patients need to take 15mg twice a day. Therefore, a box of medicine can support the patient's continuous treatment for approximately 42 days. For patients who require a longer course of treatment, it may be more suitable to choose a 15 mg × 168 tablet package. One box of this size can support a patient's treatment cycle for approximately 84 days.
It should be noted that when using bimetinib, patients should strictly follow the doctor's prescription and are not allowed to adjust the dosage or course of treatment on their own. During the treatment process, the doctor may make adjustments based on the patient's treatment response and side effects. Therefore, the patient should maintain close communication with the doctor, have regular follow-up visits, and manage the medication well.
In general, the specifications of bimetinib are flexible. The common specifications are:15mg×84 tablets and 15mg×168 tablets, which can meet the treatment needs of different patients. When patients choose drug specifications, they should choose according to their personal treatment plan and doctor's advice to ensure the smooth progress of treatment.
Reference materials:https://go.drugbank.com/drugs/DB11967
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)